<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl4" position="float"><object-id pub-id-type="doi">10.7554/eLife.19352.015</object-id><label>Table 4.</label><caption><p>Effect of Anti-Seizure drugs on postictal severe hypoxia.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.19352.015">http://dx.doi.org/10.7554/eLife.19352.015</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p><bold>Drug</bold></p> </th><th><p><bold>Principal known mechanism of action</bold></p> </th><th valign="top"><p><bold>&#916; severe hypoxia</bold></p> <p><inline-formula><mml:math id="inf2"><mml:mrow><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mstyle mathsize="normal" mathvariant="bold"><mml:mi>V</mml:mi><mml:mi>e</mml:mi><mml:mi>h</mml:mi></mml:mstyle><mml:mo>&#8722;</mml:mo><mml:mstyle mathsize="normal" mathvariant="bold"><mml:mi>D</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>g</mml:mi></mml:mstyle><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mstyle mathsize="normal" mathvariant="bold"><mml:mi>V</mml:mi><mml:mi>e</mml:mi><mml:mi>h</mml:mi></mml:mstyle></mml:mrow></mml:mfrac><mml:mo>&#160;</mml:mo><mml:mo>&#215;</mml:mo><mml:mo>&#160;</mml:mo><mml:mn>100</mml:mn><mml:mi>%</mml:mi></mml:mrow></mml:math></inline-formula></p></th></tr></thead><tbody><tr><td><p>Ethosuximide (300 mg/kg)</p></td><td valign="top"><p>T-type Ca<sup>2+</sup> Channel Blocker</p></td><td><p>+30.53&#160;&#177;&#160;19.31% *</p></td></tr><tr><td><p>Topiramate (50 mg/kg)</p></td><td valign="top"><p>Na<sup>+</sup> Channel Blocker, GABA Enhancement, AMPA Inhibition</p></td><td><p>+4.34&#160;&#177;&#160;14.07%</p> </td></tr><tr><td><p>Bumetanide (2.5 mg/kg)</p></td><td valign="top"><p>NKCC1 Transporter Inhibitor</p></td><td><p>&#8722;0.92&#160;&#177;&#160;14.72%</p> </td></tr><tr><td><p>Phenobarbital (30 mg/kg)</p></td><td valign="top"><p>GABA Receptor Agonist</p></td><td><p>&#8722;1.22&#160;&#177;&#160;13.90%</p> </td></tr><tr><td><p>Levetiracetam (250 mg/kg)</p></td><td valign="top"><p>Glutamate Release Inhibition</p></td><td><p>&#8722;14.85&#160;&#177;&#160;19.71%</p> </td></tr><tr><td><p>Phenytoin (75 mg/kg)</p></td><td valign="top"><p>Na<sup>+</sup> Channel Blocker</p></td><td><p>&#8722;15.76&#160;&#177;&#160;17.00%</p> </td></tr><tr><td><p>Lamotrigine (15 mg/kg)</p></td><td valign="top"><p>Na<sup>+</sup> Channel Blocker</p></td><td><p>&#8722;20.95&#160;&#177;&#160;17.13%</p> </td></tr><tr><td><p>Valproate (150 mg/kg)</p></td><td valign="top"><p>Na<sup>+</sup> Channel Blocker, GABA Enhancement</p></td><td><p>&#8722;24.89&#160;&#177;&#160;22.65%</p> </td></tr></tbody></table><table-wrap-foot><fn id="tblfn6"><p>All drugs were delivered by intraperitoneal injection pre-seizure.</p></fn><fn id="tblfn7"><p>Statistics reported as different from chance (one sample T-test).</p></fn><fn id="tblfn8"><p>*p&lt;0.05.</p></fn><fn id="tblfn9"><p>+ number indicates inhibition of hypoxia.</p></fn><fn id="tblfn10"><p>-number indicates potentiation of hypoxia.</p></fn></table-wrap-foot></table-wrap>